ATE315641T1 - Herstellung von thrombin therapeutischer qualitätsstufe - Google Patents

Herstellung von thrombin therapeutischer qualitätsstufe

Info

Publication number
ATE315641T1
ATE315641T1 AT95931863T AT95931863T ATE315641T1 AT E315641 T1 ATE315641 T1 AT E315641T1 AT 95931863 T AT95931863 T AT 95931863T AT 95931863 T AT95931863 T AT 95931863T AT E315641 T1 ATE315641 T1 AT E315641T1
Authority
AT
Austria
Prior art keywords
thrombin
viral
phosphate buffer
ion
production
Prior art date
Application number
AT95931863T
Other languages
English (en)
Inventor
Zbigniew Proba
Teresa Brodniewicz
Nicolas Dupuis
Trung Bui-Khac
Original Assignee
Haemacure Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemacure Biotech Inc filed Critical Haemacure Biotech Inc
Application granted granted Critical
Publication of ATE315641T1 publication Critical patent/ATE315641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95931863T 1994-09-21 1995-09-21 Herstellung von thrombin therapeutischer qualitätsstufe ATE315641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/309,583 US5506127A (en) 1994-09-21 1994-09-21 Therapeutic grade thrombin produced by chromatography

Publications (1)

Publication Number Publication Date
ATE315641T1 true ATE315641T1 (de) 2006-02-15

Family

ID=23198815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95931863T ATE315641T1 (de) 1994-09-21 1995-09-21 Herstellung von thrombin therapeutischer qualitätsstufe

Country Status (12)

Country Link
US (1) US5506127A (de)
EP (1) EP0782616B1 (de)
JP (1) JP3628703B2 (de)
AT (1) ATE315641T1 (de)
AU (1) AU711298B2 (de)
DE (1) DE69534749T2 (de)
DK (1) DK0782616T3 (de)
ES (1) ES2258264T3 (de)
NO (1) NO323460B1 (de)
PT (1) PT782616E (de)
RU (1) RU2144081C1 (de)
WO (1) WO1996009376A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
JPH07308190A (ja) * 1994-05-18 1995-11-28 Green Cross Corp:The トロンビンの製造方法
FI952196A0 (fi) * 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US5981254A (en) * 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
DE69928961T2 (de) * 1998-10-07 2006-07-13 Trinity Biotech Manufacturing Ltd. Thromboplastin-reagenzien und verfahren zur herstellung und anwendung derselben
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
WO2001023536A1 (en) * 1999-09-27 2001-04-05 International Reagents Corporation Means of stabilizing thrombin and compositions
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270014A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
RU2468032C2 (ru) * 2006-06-26 2012-11-27 Омрикс Биофармасьютикалс Инк. Способ очистки раствора тромбина от инфекционных частиц
RU2457248C2 (ru) * 2010-06-09 2012-07-27 Общество с ограниченной ответственностью фирма "Технология-Стандарт" Способ промышленного получения тромбина
CA2813747A1 (en) * 2010-10-11 2012-04-19 Chen Wang Processes for purification of proteins
WO2013091895A1 (en) * 2011-12-23 2013-06-27 Merz Pharma Gmbh & Co. Kgaa Novel method for the manufacturing of di-chain proteins for use in humans
BR112017017628A2 (pt) 2015-02-25 2018-05-08 Omrix Biopharmaceuticals Ltd. método para a purificação e quantificação de trombina e seus polipeptídeos de degradação
US20200376444A1 (en) * 2018-02-19 2020-12-03 Bayer Heal Thcare Llc Modified Filter Membrane and Method

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083957A (en) * 1974-07-26 1978-04-11 Lang John L Process for the alteration of the sex-ratio of mammals
NL7602423A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Bepaling van heparine in bloedplasma.
US4380511A (en) * 1981-08-12 1983-04-19 Miles Laboratories, Inc. Purification of bovine thrombin
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US4965203A (en) * 1987-01-28 1990-10-23 Warner-Lambert Company Purified thrombin preparations
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
JPS6440433A (en) * 1987-08-05 1989-02-10 Green Cross Corp Aqueous liquid composition of thrombin
SU1527261A1 (ru) * 1988-03-21 1989-12-07 Институт Химической И Биологической Физики Ан Эсср Способ получени тромбина
JP2832835B2 (ja) * 1988-12-21 1998-12-09 旭化成工業株式会社 ウイルス除去方法
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
CA2007545A1 (en) * 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
EP0443724B1 (de) * 1990-02-20 1999-03-17 Baxter International Inc. Gereinigtes, virusfreies menschliches Thrombin
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
JP3127232B2 (ja) * 1990-03-08 2001-01-22 ウェルファイド株式会社 蛋白質製剤の製造法
JP3093821B2 (ja) * 1991-06-19 2000-10-03 旭化成工業株式会社 銅アンモニア法再生セルロース多孔性中空糸膜の製造方法
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
US5331092A (en) * 1992-11-06 1994-07-19 Coletica Process of preparation of collagen containing in major proportion insoluble collagen and collagen having high mechanical resistance and thermal stability obtained thereby
US5229172A (en) * 1993-01-19 1993-07-20 Medtronic, Inc. Modification of polymeric surface by graft polymerization
JP2003318980A (ja) * 2002-04-24 2003-11-07 Mitsubishi Electric Corp ショートパケット用伝送フォーマット並びにゲートウェイシステム

Also Published As

Publication number Publication date
NO971104L (no) 1997-04-24
AU3515195A (en) 1996-04-09
NO323460B1 (no) 2007-05-14
US5506127A (en) 1996-04-09
EP0782616B1 (de) 2006-01-11
JPH10505753A (ja) 1998-06-09
ES2258264T3 (es) 2006-08-16
WO1996009376A1 (en) 1996-03-28
RU2144081C1 (ru) 2000-01-10
PT782616E (pt) 2006-05-31
DE69534749T2 (de) 2006-11-02
DK0782616T3 (da) 2006-05-22
EP0782616A1 (de) 1997-07-09
AU711298B2 (en) 1999-10-07
DE69534749D1 (de) 2006-04-06
NO971104D0 (no) 1997-03-11
JP3628703B2 (ja) 2005-03-16

Similar Documents

Publication Publication Date Title
ATE315641T1 (de) Herstellung von thrombin therapeutischer qualitätsstufe
EP0026970B1 (de) Verfahren zur Gewinnung von Interferon
GR3025889T3 (en) Process of preparation of a human thrombin concentrate for therapeutic use
AU1645197A (en) A pharmaceutical preparation for treating blood coagulation disorders
RU97106349A (ru) Производство и продукты тромбина терапевтической степени чистоты
Main et al. Purification of horse serum cholinesterase by preparative polyacrylamide gel electrophoresis
JPH0586097A (ja) 上清ｉｖ、特にｉｖ−４またはコーンフラクシヨンｖまたはそれと類似の上清または画分からヒトアルブミンを単離する方法
EP0669342B1 (de) Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
US4510084A (en) Method of producing an antithrombin III-heparin concentrate or antithrombin III-heparinoid concentrate
ES8602538A1 (es) Un metodo de mejorar las propiedades de adsorcion dinamica de zeolita de aluminosilicato sodico nodulizadas
JPH06172375A (ja) オリゴマンヌロン酸を重合度によって分離する方法
US3957582A (en) Purification of urokinase
EP0396022B1 (de) Verfahren zur Isolierung des Blutgerinnungsfaktors IX
JP3471379B2 (ja) ヒトアンチトロンビン−ｉｉｉの調製方法
ES480636A1 (es) Un procedimiento para la purificacion de liquidos o, la re- generacion de soluciones absorbentes.
EP0354354A2 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X
SK30893A3 (en) Method of gaining of enzymes from proenzymes
Viscarello et al. Purification of human leukocyte elastase and cathepsin G by chromatography on immobilized elastin
JPS5598117A (en) Purification of gamma-globulin derivative
GB1507215A (en) Processes for producing immunoregulatory preparations
JPS54107584A (en) Preparation of pure heparinase
GB911223A (en) Diethylyaminoethyl celluloses
JPS62122588A (ja) 純コンドロイチナ−ゼの製造法
KR910003112A (ko) 에피데르민의 수득, 분리 및 정제방법
JPS54107587A (en) Preparation of pure chondroitinase c

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0782616

Country of ref document: EP

REN Ceased due to non-payment of the annual fee